The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hmm..... " And no, it doesn't depend on whether on not it is making money, it depends on the potential to make money in the future."
Its worth less if its not making money, do you agree?
Our potential is just too tempting!
I think it’s hard to stop a big pharma from taking us over
Would be great if we stay independent for a few years
Yes immaterial, but our best guide to what the value might be in absence of any other information. And no, it doesn't depend on whether on not it is making money, it depends on the potential to make money in the future.
Hope shorters can sleep tonight!
It depends if its making money or not.
Its immaterial what AVCT paid for it.
We spent £31m outright plus £16m business performance payments. We already had our own small Avacta Diagnostics division. How much have pharma M&A valuations increase in the last year?! Should be worth £50m+. I’m not saying we would sell it, just that it has material value and we get very little news about it.
Bridge, current Mk cap is £180m If the Dx was worth somewhere between £18-36m then its worth maybe 5-10p.
Now there's an idea.
Our Diagnostics purchases are probably worth around 20p in the current share price yet given no weight at all. Maybe we should just sell it off and focus on therapeutics.
And anyway if it was positive news the share price would drop just like it does with every other positive bit of news !
Nothing will be big tomorrow.
Stop bigging it up
It’s just results and nothing new
Usual Hurst drivel.
Size buyer stepping in, above 50p.
Usual suspects on the bid.
US buyer wants price and size NOW
"Diagnostics - Significant progress towards establishing a fully integrated in vitro diagnostics business with first transformational acquisition"
I wonder what happened to that? - after our acquisitions it all went quiet
The truth ....is Rapunzel will have had a shorter sleep than you at that rate
Everyone is building this up to be more than it is. Its a presentation of results...that is all
Let's see this rise to at least 70p this week starting from tomorrow. ;)
If they get rid of Smiffy and TG the share price will be off to the races. The overhang of these two is bigger than the placing itself.
Anything less would be a massive disappointment gje. Imagine if they just present the results which is the purpose of the update.
Nice one Prof - demonstrates how bright you are.
Never been a bigger day in avacta history....
So let's get this right. Tomorrow we're expecting:
- an announcement that AS is being replaced
- some brilliant explanation for the 50p raise, such as, we have been bought into by a european health fund at 50p and they're going to help sell avacta for 5bn in a month
- Big, big news on the first 2w cohort that the ultimate cure has been discovered.
It needs to go up by at least 150% to get confidence back. Bare that in mind Alastair
This should cut through the 50s fairly sharply